跳至主要内容
临床试验/CTRI/2025/04/084614
CTRI/2025/04/084614尚未招募不适用

A STUDY TO ASSESS THE CORRELATION BETWEEN BALA VRIDDHIKAR BHAVA & IMMUNITY, WITH A CLINICAL EVALUATION OF THE IMPACT OF YUKTIKRUTA BALA ON IMMUNE MODULATION

All India Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 371 人开始时间: 2025年5月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
371
试验地点
1
主要终点
Evaluation of association between Bala Vriddhikara Bhava and Immunity in apparently healthy individual.(Phase II)

研究概览

简要总结

The study will be carried out in 3 phase. In Phase I Bala Vriddhikar Bhava Quetionnaire ill be prepared and validated.

Phase II of study aims to scientifically and clinically explore the relationship between Bala Vriddhikara Bhava and immunity, using tools such as Bala Vriddhikara Bhava questionnaire and Immune Status Questionnaire, complete blood count (CBC) with ESR, differential leukocyte count (DLC), C-reactive protein (CRP), and serum immunoglobulins. By assessing the "bala" of apparently healthy individuals through these biomarkers, we seek to identify which types of bala—Sahaj, Kalaj, or Yuktikruta—are lacking. This understanding will help inform strategies for disease prevention by enhancing the specific deficit factor, ultimately leading to improved health outcomes.

In Phase III the apparently healthy subjects of survey study with two or more than two aberrant investigation test results will be recruited in Clinical study based on the inclusion criteria and will be given  Rasayana Churna along with Madhu06 gram daily once for 60 days which aims to provide evidence that an individual’s "Bala" can be objectively enhanced through current biomarkers. Additionally, the study seeks to improve the Yuktikruta  Bala of individuals, contributing to better health result.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Apparently healthy subjects of either gender in the age group of 18 – 45 years, irrespective of their caste, religion, socio-economic status etc.
  • will be included Prior informed written consent will be taken Apparently healthy subjects of Survey study with two or more than two aberrant investigation test results will be included for Clinical study.

排除标准

  • Apparently healthy subjects who are not willing to take part in the study.
  • Pregnant and lactating females Subject taking any kind of medication for previous illness in past 12 months.
  • History of any systemic diseases, hereditary diseases, autoimmune disease and other co-morbidities.

结局指标

主要结局

Evaluation of association between Bala Vriddhikara Bhava and Immunity in apparently healthy individual.(Phase II)

时间窗: At the end of Phase II

次要结局

  • Correction of the aberrant Immunity biomarkers (CBC with ESR, DLC, CRP and Sr. Immunoglobulin) of apparently healthy individuals.(Phase III)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Sheetal

All India Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验